Herein, we found that when its expression was increased, SNHG12 reduced the overall survival of GC patients and promoted GC tumorigenesis by activating the AKT/GSK-3β pathway and binding with the RNA binding protein ELAVL1 (also known as HuR) and stabilizing YWHAZ expression. This evidence concerns the gene AKT1 and gastric cancer.